Contrariwise, tirzepatide not only reduced albuminuria but also significantly slowed the rate of eGFR decline compared with insulin glargine in patients with T2D 82
They're also banned-substance tested, which adds a layer of trust for athletes and anyone serious about ingredient safety
Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
Other Side Effects: Nausea or digestive changes can also contribute to feeling drained
Besides, in 2023, Eli Lilly invested in defending pramlintide patents against challengers, which reflected an intense competition in the obesity and diabetes space